Call for Abstract

37th World Congress on Pharmacology, will be organized around the theme “Tracking and Tackling Drug Developments in Pharmacology”

Pharmacology 2024 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharmacology 2024

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Pharmacology is a branch in science concerned with the effects of the drugs on living organisms (pharmacodynamics) and the effects of living organisms with the drugs (pharmacokinetics). This subject embodies drug composition and properties, interactions, toxicology, therapy, and medicinal uses such as application and anti-pathogenic capabilities. Pharmacology is subdivided into two categories as mentioned above, pharmacodynamics and pharmacokinetics.

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behaviour. There are two main branches of neuropharmacology: behavioural and molecular. Behavioural neuropharmacology focuses on the study of how drugs affect human behaviour (neuropsychopharmacology), including the study of how drug dependence and addiction affect the human brain.

Toxicology is the scientific study of adverse effects that occur in living organisms due to chemicals. It involves observing and reporting symptoms, mechanisms, detection and treatments of toxic substances, in particular relation to the poisoning of humans. It includes environmental agents and chemical compounds found in nature, as well as pharmaceutical compounds that are synthesized for medical use by humans.

Forensic toxicology is a specialized branch of toxicology that focuses on the analysis of substances in biological samples for legal and investigative purposes. It involves the identification and quantification of drugs, alcohol, and other toxic substances in post-mortem specimens, such as blood, urine, and tissues. Forensic toxicologists play a crucial role in determining the presence and concentration of these substances in cases involving drug overdoses, driving under the influence (DUI), workplace accidents, and suspicious deaths.

Molecular and clinical pharmacology is a multidisciplinary field that combines the study of molecular mechanisms of drugs with their clinical applications. It focuses on understanding how drugs interact with specific molecules, such as receptors or enzymes, at the molecular level to produce their therapeutic effects. This knowledge is then translated into clinical practice to optimize drug therapy for patients. Molecular pharmacology investigates the mechanisms of drug action, including drug-target interactions, signal transduction pathways, and genetic factors that influence drug response.

Concept of Pharmacovigilance and its Significance enhances the impact of pharmacovigilance on patient welfare and public health and to know what is Pharmacovigilance. This track gives a brief discussion on Pharmacovigilance role in healthcare system. Pharmacovigilance legislation gives an outlook on the rules and laws to follow in Pharmacovigilance practice. The Role of Pharma industries in the improvement of Pharmacovigilance system is very crucial to maintain the safety data, Detection and Evaluation of drug safety signals through manual and medical devices reporting.

In drug development, preclinical development, also named preclinical studies and nonclinical studies, is a stage of research that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative testing and drug safety data are collected. The main goals of pre-clinical studies are to determine the safe dose for first-in-man study and assess a product's safety profile. Products may include new medical devices, drugs, gene therapy solutions and diagnostic tools.

In drug development, preclinical development, also named preclinical studies and nonclinical studies, is a stage of research that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative testing and drug safety data are collected. The main goals of pre-clinical studies are to determine the safe dose for first-in-man study and assess a product's safety profile. Products may include new medical devices, drugs, gene therapy solutions and diagnostic tools.

 

Cardiovascular Pharmacology deals with the study of the effects of drugs upon the heart or circulatory system. It mainly contributes to the safety profile of potential new drugs and provides pharmacological data that can be used for optimization of further compounds and the ultimate selection of compounds suitable for clinical development. The cardiac drugs affect the function of the heart in three main ways.

In a context of severe pharmaceutical pollution, “Ecopharmacovigilance” (EPV) has been an area of novel interest. It aims to ensure that significant environmental issues associated with pharmaceuticals in the environment are identified in a timely way, and managed appropriately. EPV has become a research hotspot as a comprehensive and boundary science in Europe and North America, and regulatory requirements governing the comprehensive environmental risk assessment (ERA) of pharmaceuticals exist in these regions.

Drug safety testing is happening in a growing number of countries including Austria, Canada, Colombia, Mexico, the Netherlands, Switzerland, United States and the UK. This briefing discusses testing using sophisticated analytical equipment, not DIY kits that cannot identify many contaminants, or strength. Drug safety testing is happening in a growing number of countries including Austria, Canada, Colombia, Mexico, the Netherlands, Switzerland, United States and the UK.

Immunopharmacology and Immunotoxicology is a bimonthly peer-reviewed medical journal that covers preclinical and clinical studies on the regulatory effects of various agents on immunocompetent cells, as well as the immunotoxicity exerted by xenobiotics and drugs. Hence, the journal encompasses a broad range of pathologies (e.g. acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation, and primary and secondary immunodeficiency’s).

Ophthalmic diseases include both those analogous to systemic diseases (e.g., inflammation, infection, neuronal degeneration) and not analogous (e.g., cataract, myopia). Many anterior segment diseases are treated pharmacologically through eye drops, which have an implied therapeutic index of local therapy. Unlike oral dosage forms administered for systemic diseases, eye drops require patients not only to adhere to treatment, but to be able to accurately perform-i.e., instill drops correctly.

Clinical pharmacy is the discipline of Pharmacy where pharmacists are meant to provide patient care which helps in optimizing the use of drugs and improves health, wellness, and prevents diseases. This session is dealt with topics like basic components of clinical pharmacy practice Prescribing drugs, Reviewing drug use, Administering drugs, Counselling, Documenting professional services, Consulting, Preventing Medication Errors etc.,

All pharmaceutical researchers know the feeling. Somewhere out there must be that elusive molecule — one that will inhibit this enzyme or activate that receptor in the way they want, and without causing unwanted side-effects. But finding it is another matter. For small-molecule drugs — the mainstay of the pharmaceutical industry — time-consuming and expensive screening is needed to pick out promising candidates from the vast number of natural and synthetic compounds available.

The pharmaceutical and Toxicological industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.

Safety pharmacology evaluations are an essential step in assessing acute and potentially life-threatening risks of novel pharmaceuticals as part of an IND-enabling program. Second-tier safety pharmacology studies can be used to determine mechanistic effects on vital functions and evaluate potential adverse effects on organ systems such as renal and gastrointestinal systems.

Statistical analysis is one of the foundations of evidence-based clinical practice, a key in conducting new clinical research and in evaluating and applying prior research. In this paper, we review the choice of statistical procedures, analyses of the associations among variables and techniques used when the clinical processes being examined are still in process. We discuss methods for building predictive models in clinical situations, and ways to assess the stability of these models and other quantitative conclusions.

Adverse drug reactions can be considered a form of toxicity; however, toxicity is most commonly applied to effects of over ingestion (accidental or intentional) or to elevated blood levels or enhanced drug effects that occur during appropriate use (e.g., when drug metabolism is temporarily inhibited by a disorder or another drug). For information on toxicity of specific drugs see the table Symptoms and Treatment of Specific Poisons.

Biochemical pharmacology uses the methods of biochemistry, biophysics, molecular biology, structural biology, cell biology, and cell physiology to define the mechanisms of drug action and how drugs influence the organism by studies on intact animals, organs, cells, subcellular compartments and individual protein molecules. The biochemical pharmacologist also uses drugs as probes to discover new information about biosynthetic and cell signalling pathways and their kinetics, and investigates how drugs can correct the biochemical abnormalities that are responsible for human illness, thus enabling the elucidation of pathophysiological mechanisms that pave the way for further drug discover